Skip to main
GRDN
GRDN logo

GRDN Stock Forecast & Price Target

GRDN Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Guardian Pharmacy Services Inc. is positioned for growth due to its strong technological capabilities that enhance value-based care discussions and improve efficiency in recently acquired operations. The company benefits from a significant market share within its operating segment and has strong core trends that suggest promising earnings power opportunities, particularly from newly integrated facilities. Additionally, the utilization of approximately 80 robotic dispensing machines has improved operational accuracy and significantly reduced the time to fulfill requests, further supporting the company’s efficiency and service quality.

Bears say

The financial outlook for Guardian Pharmacy Services Inc. is clouded by several significant risks that could adversely impact its performance. Key concerns include potential regulatory and reimbursement changes, challenges in managing relationships with long-term care facilities (LTCFs), and supply chain disruptions that may hinder operations. Additionally, the company faces difficulties in hiring and retaining clinical staff, which could affect service delivery, alongside the critical reliance on IT and technology assets to manage operations and integrate acquisitions effectively.

GRDN has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Guardian Pharmacy Services Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Guardian Pharmacy Services Inc (GRDN) Forecast

Analysts have given GRDN a Buy based on their latest research and market trends.

According to 2 analysts, GRDN has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $32, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $32, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Guardian Pharmacy Services Inc (GRDN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.